CNC
CENTENE CORP
NYSE: CNC · St Louis, MO · Healthcare
$70.17-1.07 (-1.50%)Closed
Market Cap$34.66B
Cash$24.15Bmost recent
Runwayprofitable
P/E (TTM)—EPS $-13.53
52-Wk Range$31.80 – $71.24
Avg Volume6.1M3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$70.17+13.9%
Pipeline
Drug candidates sponsored by CENTENE · ClinicalTrials.gov
No trials found for this sponsor.
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for CNC. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.